Abstract
Background and Purpose
Small improvements in clinical outcomes after intracerebral hemorrhage (ICH) can have a substantial impact on overall health care costs, yet little data exists on the costs associated with the most commonly studied clinical outcomes in this type of stroke.
Methods
The Factor Seven for Acute Hemorrhagic Stroke (FAST) trial was a randomized, multicenter, double-blind, placebo-controlled trial conducted between May 2005 and February 2007 at 122 sites in 22 countries. The resource utilization associated with health care services was prospectively recorded in all patients up to day 90 after stroke onset. Measures of disability included the modified Rankin Scale (mRS), and the Barthel Index (BI), while the National Institutes of Health Stroke Scale (NIHSS) measured neurological impairment. Relationships among resource use, health care costs, and disability/impairment were evaluated using one-way ANOVA with Bonferroni testing.
Results
A total of 820 patients had complete data. Length of stay (LOS) and total costs varied significantly by mRS scores at 90 days (P < 0.0001). Mean LOS for mRS scores 0–5 and dead were 16, 29, 40, 61, 80, 79, and 14 days, respectively; all categories of mRS had significantly different total LOS from their adjacent categories except mRS 0–1 and mRS 4–5. Mean total costs were $9,500, $15,500, $18,700, $27,400, $27,300, $27,300, and $8,100, respectively; costs rose incrementally up to mRS 3, but were not significantly different for mRS 3, 4, and 5. Total LOS and total costs varied significantly by the Barthel Index scores (P < 0.0001) and NIHSS scores (P < 0.0001), yet significant incremental differences were only observed for the Barthel Index.
Conclusion
Health care costs vary significantly by levels of disability as measured by the mRS, but costs do not vary across the full range of mRS outcomes. The mRS is more informative than the Barthel index and NIHSS for discriminating the resource use and costs associated with different levels of disability after ICH.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lee WC, Christensen MC, Joshi A, Pashos C. Long-term cost of stroke sub-types among medicare beneficiaries. Cerebrovasc Dis. 2007;23:57–65.
Navarrete P, Hart WM, Lopez J, Christensen MC. The societal costs of intracerebral haemorrhage in Spain. Eur J Neurol. 2007;14:556–62.
Taylor TN, Torner JC, Meyer JW. Lifetime cost of stroke in the United States. Stroke. 1996;27:1459–66.
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.
Dodel RC, Haacke C, Zamzow K, Paweilik S, Spottke A, Rethfeldt M, et al. Resource utilization and costs of stroke unit care in Germany. Value Health. 2004;7:144–52.
Spieler J-F, Lanoë J-L, Amarenco P. Costs of stroke care according to handicap levels and stroke subtypes. Cerebrovasc Dis. 2004;17:134–42.
Spratt N, Wang Y, Levi C, Ng K, Evans M. A prospective study of predictors of prolonged hospital stay and disability after stroke. J Clin Neurosci. 2003;10:665–9.
Dawson J, Lees JS, Chang T-P, Walters MR, Myzoon A, Davis SM, et al. Association between disability measures and health care costs after initial treatment for acute stroke. Stroke. 2007;38:1839–98.
Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol. 2004;61:1066–70.
Mayer S, Brun NC, Begtrup K, Broderick J, Davis S, Diringer M, Skolnick BE, Steiner T. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. New Engl J Med 2008;358(20):2127–37.
Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. MD State Med J. 1965;14:61–5.
Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–70.
Ingenix Inc. 2007 DRG Expert: A comprehensive guidebook to the DRG classification system. Available on-line at: http://www.coderscentral.com/07_drg_expert.htm.
Ingenix Inc. 2007 National Fee Analyzer: Charge data for evaluating fees nationally. Available on-line at: http://www.pohly.com/books/nationalfeeanalyzer.html.
Center for Medicare and Medicaid Services. Medicare Program; Home Health Prospective Payment System Rate Update for Calendar Year 2007 and Deficit Reduction Act of 2005 Changes to Medicare Payment for Oxygen Equipment and Capped Rental Durable Medical Equipment; Final Rule. November 9, 2006. Available on-line at: http://www.cms.hhs.gov/quarterlyproviderupdates/downloads/cms1304f.pdf.
Weimar C, Weber C, Wagner M, et al. Management patterns and health care use after intracerebral hemorrhage. A cost-of-illness study from a societal perspective in Germany. Cerebrovasc Dis. 2003;15:29–36.
Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke. Stroke. 2007;38:1655–711.
Broderick J, Connolly S, Feldman E, Hanley D, Kase C, Krieger D, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update. Stroke. 2007;38:2001–23.
Acknowledgements
This trial was funded by Novo Nordisk A/S. MC Christensen is an employee of Novo Nordisk A/S. S. Morris has received consultancy fees from Novo Nordisk A/S for his methodological and statistical support in regards to this research.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Christensen, M.C., Morris, S. Association Between Disability Measures and Short-term Health Care Costs Following Intracerebral Hemorrhage. Neurocrit Care 9, 313–318 (2008). https://doi.org/10.1007/s12028-008-9124-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-008-9124-5